UA90263C2 - COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED <http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=ru_ru&FT=D&date=20091224&CC=NZ&NR=549792A&KC=A> - Google Patents

COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED <http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=ru_ru&FT=D&date=20091224&CC=NZ&NR=549792A&KC=A>

Info

Publication number
UA90263C2
UA90263C2 UAA200610358A UAA200610358A UA90263C2 UA 90263 C2 UA90263 C2 UA 90263C2 UA A200610358 A UAA200610358 A UA A200610358A UA A200610358 A UAA200610358 A UA A200610358A UA 90263 C2 UA90263 C2 UA 90263C2
Authority
UA
Ukraine
Prior art keywords
compositions
molecularly dispersed
publicationdetails
biblio
espacenet
Prior art date
Application number
UAA200610358A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Адриан Функе
Торстен Вагнер
Original Assignee
Байер Шеринг Фарма Акциенгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Шеринг Фарма Акциенгезелльшафт filed Critical Байер Шеринг Фарма Акциенгезелльшафт
Publication of UA90263C2 publication Critical patent/UA90263C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
UAA200610358A 2004-03-10 2005-03-10 COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED <http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=ru_ru&FT=D&date=20091224&CC=NZ&NR=549792A&KC=A> UA90263C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075713 2004-03-10

Publications (1)

Publication Number Publication Date
UA90263C2 true UA90263C2 (en) 2010-04-26

Family

ID=34928104

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200610358A UA90263C2 (en) 2004-03-10 2005-03-10 COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED <http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=ru_ru&FT=D&date=20091224&CC=NZ&NR=549792A&KC=A>

Country Status (12)

Country Link
CN (1) CN1980636A (sr)
AR (1) AR048002A1 (sr)
DE (1) DE602005022952D1 (sr)
GT (1) GT200500044A (sr)
MY (1) MY143870A (sr)
PA (1) PA8625901A1 (sr)
PE (1) PE20060004A1 (sr)
RS (1) RS50975B (sr)
SV (1) SV2005002043A (sr)
TW (2) TW200840587A (sr)
UA (1) UA90263C2 (sr)
UY (1) UY28802A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109420B (zh) * 2016-08-11 2018-07-06 吴启旸 依普利酮固体分散体及其制剂

Also Published As

Publication number Publication date
TW200609000A (en) 2006-03-16
DE602005022952D1 (de) 2010-09-23
SV2005002043A (es) 2005-11-04
CN1980636A (zh) 2007-06-13
AR048002A1 (es) 2006-03-15
PE20060004A1 (es) 2006-02-16
TW200840587A (en) 2008-10-16
MY143870A (en) 2011-07-15
PA8625901A1 (es) 2006-07-03
GT200500044A (es) 2005-10-31
UY28802A1 (es) 2005-10-31
RS50975B (sr) 2010-10-31

Similar Documents

Publication Publication Date Title
IL177893A0 (en) Compositions comprising drospirenone molecularly dispersed
CR8630A (es) Solidos supersaturados estabilizados de drogas lipofilicas
TR200001810A2 (tr) Hemen Eriyen Oral Dozaj Formülasyonu.
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
WO2008033351A3 (en) Multimodal abuse resistant and extended release formulations
MA37809A1 (fr) Administration de médicament biodégradable pour compositions hydrophobes
IL162671A0 (en) Micronized pharmaceutical or nutraceutical powder with immediate release
WO2005004917A3 (en) Pharmaceutical composition for solubility enhancement of hydrophobic drugs
PL1916994T3 (pl) Wytwarzanie kompozycji farmaceutycznej o szybkim uwalnianiu leków nierozpuszczalnych w wodzie i kompozycje farmaceutyczne otrzymywane sposobem według wynalazku
WO2008023362A3 (en) Use of a combination of methotrexate and an a3ar agonist for the treatment of cancer
FR2878158B1 (fr) Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
WO2007100382A3 (en) Orally administrable gallium compositions and method of use
UA90263C2 (en) COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED &lt;http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&amp;adjacent=true&amp;locale=ru_ru&amp;FT=D&amp;date=20091224&amp;CC=NZ&amp;NR=549792A&amp;KC=A&gt;
IL179021A (en) Tetrahydroisoquinoline sulfonamide derivatives, pharmaceutical compositions containing the derivative and the use thereof for the preparation of medicaments
WO2007012479A3 (en) Benzylpiperazine derivates and their medical use
EP1980255A4 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING SYNTHETIC STEROID DERIVATIVES SUCH AS TIBOLONE, MINERALS SUCH AS CALCIUM AND ACTIVE METABOLITE OF VITAMIN D (CALCITRIOL) FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS AND MENOPAUSE
WO2007086911A3 (en) Stable nanoparticle formulations
WO2006039268A3 (en) Pharmaceutical formulations containing vitamin e tpgs molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations
WO2007135295A3 (fr) Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur préparation, compositions les contenant et utilisation
WO2007135293A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur préparation, compositions les contenant et utilisation
TNSN08442A1 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
HK1116094A (en) Manufacturing of quick release pharmaceutical composition of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
CU20060177A7 (es) Soluciones sólidas supersaturadas estabilizadas de drogas esteroides
TH135239A (th) องค์ประกอบทางเภสัชกรรมประเภทของแข็งซึ่งประกอบรวมด้วยแอมโลดิพีนและโลซาร์แทน
TH84342B (th) สารผสมทางเภสัชกรรมที่ประกอบไปด้วยอิมาตินิปและสารชะลอการปลดปล่อยตัวยา